ZNTL Earnings Date: Nov 10, 2026 (Estimated) — Zentalis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is ZNTL's next earnings date?
Zentalis Pharmaceuticals, Inc. (ZNTL) is expected to report earnings on Tuesday, November 10, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.58.
How did ZNTL do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Zentalis Pharmaceuticals, Inc. posted EPS of -$0.59 versus the -$0.49 estimate, a miss of 28.3%. Revenue was $0. The stock's 1-day post-earnings move was -15.6%.
How much does ZNTL stock move after earnings?
ZNTL beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.1% (up or down) in the day after earnings.
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.49 | -0.59 | -28.26% | $0 | ❌ Miss | -15.60% | -17.00% | -20.20% |
| 2026-05-12 | Q1 2026 | -0.52 | -0.50 | +3.85% | $0 | ✅ Beat | +0.00% | -17.29% | -17.76% |
| 2026-03-26 | Q4 2025 | -0.53 | -0.49 | +7.55% | $0 | ✅ Beat | -21.35% | -1.50% | +59.18% |
| 2025-11-10 | Q3 2025 | -0.48 | -0.37 | +22.92% | $0 | ✅ Beat | +6.06% | +0.00% | +7.58% |
| 2025-08-06 | Q2 2025 | -0.54 | -0.37 | +31.48% | $0 | ✅ Beat | +5.07% | +7.97% | +26.81% |
| 2025-03-26 | Q4 2024 | -0.78 | -0.66 | +15.38% | $26.9M | ✅ Beat | +1.70% | -23.01% | -18.75% |
| 2024-11-12 | Q3 2024 | -0.91 | -0.56 | +38.46% | $0 | ✅ Beat | +5.66% | -19.41% | -15.63% |
| 2024-08-09 | Q2 2024 | -0.84 | -1.24 | -47.62% | $0 | ❌ Miss | -9.37% | -3.32% | -8.46% |
Showing last 8 quarters.